SULT2A1 and prostate carcinoma: Interestingly, we note that LXR activation might increase SULT2A1 mRNA levels in human LNCaP prostate cancer cells based on previous research,55 and the formation of a range of oxysterol sulfates shows antagonistic effects on LXRs.56